The presence of circulating tumor DNA (ctDNA) in patients with human epidermal growth factor receptor 2 (HER2)-positive ...

Labcorp added to its suite of tests designed to detect cancer recurrence much earlier than traditional imaging.

Differentiating tunnel and abscess/inflammatory nodule recurrence refines surgical outcomes after wide excision in patients ...

Cancer’s cruelest trick is its ability to disappear, only to reappear years later in a new organ or a familiar scar. The fear ...

DESTINY-Breast05 is a large phase 3 trial in women with HER2-positive early-stage breast cancer who had chemotherapy and ...

IDH-mutant glioma, caused by abnormalities in a specific gene (IDH), is the most common malignant brain tumor among young ...

One large study found that more advanced cases of colorectal cancer had a higher likelihood of returning. For example, if participants had stage 3 colon cancer, almost 25 percent experienced a ...

Primary disease recurrence after renal transplantation accounts for 7–8% of graft losses Disease recurrence after paediatric renal transplantation can be associated with a high or low risk of graft ...

For most people with uterine cancer, treatment is effective, but in some people, uterine cancer can recur either in the uterus or in another part of the body. Share on Pinterest Getty Images/FG Trade ...

Ductal carcinoma in situ (DCIS) is a low-risk form of early-stage breast cancer. Women with DCIS can have radiation after the tumor is removed to lower the risk that the cancer could come back. A new ...

Serum Androgens As Prognostic Biomarkers in Castration-Resistant Prostate Cancer: Results From an Analysis of a Randomized Phase III Trial mRNA from 1,017 patients with ER-positive primary breast ...